real-time news and commentary for investors
Friday, Apr 19
Goldman Sachs thinks today's weakness in Intuitive Surgical (ISRG -4.7%) is a buying...
Goldman Sachs thinks today's weakness in Intuitive Surgical (ISRG -4.7%) is a buying opportunity, on the back of what it calls a "solid" Q1 report. Procedure growth may have fallen short of expectations, but Goldman thinks the slowdown looks consistent with trends across the space (seasonality, declines in hospital admissions), and the impact from negative headlines, while unclear and will take time to prove out, are not material.